A Single Oral Dose Study Of PF-06409577 In Healthy Adult Subjects

NCT02286882 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
39
Enrollment
INDUSTRY
Sponsor class

Stopped The trial was terminated prematurely on June 19, 2015 for business reasons. There were no safety concerns in the study which led to the decision.

Conditions

Interventions

Sponsor

Pfizer